Viewing Study NCT02701634


Ignite Creation Date: 2025-12-25 @ 2:32 AM
Ignite Modification Date: 2025-12-26 @ 1:07 AM
Study NCT ID: NCT02701634
Status: TERMINATED
Last Update Posted: 2018-12-26
First Post: 2016-02-24
Is NOT Gene Therapy: False
Has Adverse Events: True

Brief Title: Efficacy and Tolerability of Entospletinib in Combination With Systemic Corticosteroids as First-Line Therapy in Adults With Chronic Graft Versus Host Disease (cGVHD)
Sponsor: Gilead Sciences
Organization: